SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-23-012347
Filing Date
2023-05-05
Accepted
2023-05-05 16:10:11
Documents
1
Period of Report
2023-04-28

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4765
  Complete submission text file 0000899243-23-012347.txt   6151
Mailing Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037 (858) 875-2400
Ambrx Biopharma Inc. (Issuer) CIK: 0001836056 (see all company filings)

IRS No.: 571147346 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O AMBRX BIOPHARMA INC. 10975 NORTH TORREY PINES ROAD LA JOLLA CA 92037
Business Address
Aromando Andrew (Reporting) CIK: 0001976455 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40505 | Film No.: 23893902